6-(1,1,7-Trioxo-1,2,3,4,5,6,7,8-octahydro-1lambda*6*-cyclopenta[b]thieno[2,3-e]pyridin-8-yl)-pyridine-2-carbonitrile

ID: ALA3138602

PubChem CID: 11151569

Max Phase: Preclinical

Molecular Formula: C16H13N3O3S

Molecular Weight: 327.37

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#Cc1cccc(C2C3=C(CCC3=O)NC3=C2S(=O)(=O)CC3)n1

Standard InChI:  InChI=1S/C16H13N3O3S/c17-8-9-2-1-3-10(18-9)15-14-11(4-5-13(14)20)19-12-6-7-23(21,22)16(12)15/h1-3,15,19H,4-7H2

Standard InChI Key:  SEBALDIRDDKSDU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    2.6880    0.4887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4728    0.7504    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.9747    0.8970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2654    0.4901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6961   -0.3265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2695   -0.3459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9869   -0.7500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9707    1.7206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2575    2.1289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4698    0.7400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4792   -0.5723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9627    0.0914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1729    3.7650    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8835    1.3340    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2964    0.7543    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5403    3.3566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4763   -0.6076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2535    2.9525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0178    0.0638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2123    1.5207    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6800    2.1358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6760    2.9594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9627    3.3760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  1  0
  5  1  2  0
  6  7  1  0
  7  5  1  0
  8  3  1  0
  9  8  2  0
 10  4  1  0
 11  5  1  0
 12  2  1  0
 13 16  3  0
 14  2  2  0
 15  2  2  0
 16 18  1  0
 17  6  1  0
 18  9  1  0
 19 10  1  0
 20 10  2  0
 21  8  1  0
 22 21  2  0
 23 22  1  0
 12 11  1  0
  4  6  2  0
 17 19  1  0
 18 23  2  0
M  END

Associated Targets(Human)

KCNJ11 Tclin Sulfonylurea receptors; K-ATP channels (596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 327.37Molecular Weight (Monoisotopic): 327.0678AlogP: 1.29#Rotatable Bonds: 1
Polar Surface Area: 99.92Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: -0.81CX LogD: -0.81
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.83Np Likeness Score: -0.92

References

1. Carroll WA, Altenbach RJ, Bai H, Brioni JD, Brune ME, Buckner SA, Cassidy C, Chen Y, Coghlan MJ, Daza AV, Drizin I, Fey TA, Fitzgerald M, Gopalakrishnan M, Gregg RJ, Henry RF, Holladay MW, King LL, Kort ME, Kym PR, Milicic I, Tang R, Turner SC, Whiteaker KL, Yi L, Zhang H, Sullivan JP..  (2004)  Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractions.,  47  (12): [PMID:15163196] [10.1021/jm030356w]

Source